Malcolm A. Young - Concepedia

Author

Malcolm A. Young

Also Known As

Bonnie Shaddinger, M A Young, M YOUNG, M. A. Young, M. YOUNG, M. Young, M.A. Young, Malcolm A Young, Malcolm A. Young, Malcolm Young

Publications

958

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United States)Research Triangle Park Foundation City, University of London Wellcome Library Indivior (United States)

About

Malcolm A. Young is an author at GlaxoSmithKline (United States) specializing in medicine, liver physiology, and metabolism.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	436
2	Health Sciences	3	3	242
3	Social Sciences	2	2	108
4	Biochemistry	2	2	67
5	Engineering	1	1	52

Malcolm A. Young

Publications

724

Citations

H-Index

Page 1

	Year	Citations
ISEC: a program to calculate insulin secretion Roman Hovorka, P.A. Soons, Malcolm A. Young Computer Methods and Programs in Biomedicine ObesityMetabolic SyndromeInsulin ManagementDiabetesPhysiology	1996	173
Interactions of risk factors in predicting suicide Malcolm A. Young, Louis Fogg, William A. Scheftner, American Journal of Psychiatry Psychological Co-morbiditiesSubstance UseSuicide ResearchMental HealthPsychology	1994	77
Measuring prehepatic insulin secretion using a population model of C-peptide kinetics: accuracy and required sampling schedule Roman Hovorka, Eftychia Koukkou, D. Southerden, Diabetologia Metabolic SyndromeBody CompositionLiver PhysiologyPhysiologyDiabetes	1998	54
Human absorption, distribution, metabolism and excretion properties of drug molecules: a plethora of approaches Claire Beaumont, Graeme Young, Tom Cavalier, British Journal of Clinical Pharmacology Pharmaceutical ScienceEngineeringPhysiologically-based Pharmacokinetic ModelingPharmacological StudyDrug Purity	2014	52
Population Pharmacokinetics of a Monthly Buprenorphine Depot Injection for the Treatment of Opioid Use Disorder: A Combined Analysis of Phase II and Phase III Trials Aksana K. Jones, Eliford Ngaimisi, Mathangi Gopalakrishnan, Clinical Pharmacokinetics	2020	48
Pharmacokinetics of troglitazone, a PPAR-γ agonist, in patients with hepatic insufficiency Peter Ott, L Ranek, Malcolm A. Young European Journal of Clinical Pharmacology Hepatic InsufficiencyHepatologyMedicineLiver PhysiologyPpar-γ Agonist	1998	34
Albiglutide does not impair the counter‐regulatory hormone response to hypoglycaemia: a randomized, double‐blind, placebo‐controlled, stepped glucose clamp study in subjects with type 2 diabetes mellitus Marcus Hompesch, Angela R. Jones-Leone, Molly C. Carr, Diabetes Obesity and Metabolism	2014	31
A field test of Motto's risk estimator for suicide David C. Clark, Malcolm A. Young, William A. Scheftner, American Journal of Psychiatry Quality Of LifePsychological Co-morbiditiesPsychopathologyPsychiatryRisk Scale	1987	31
Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder Céline M. Laffont, Eliford Ngaimisi, Mathangi Gopalakrishnan, Frontiers in Pharmacology	2022	26
Effect of Renal Impairment on the Pharmacokinetics, Efficacy, and Safety of Albiglutide Malcolm A. Young, Jeffrey A. Wald, Jessica Matthews, Postgraduate Medicine	2014	25

Page 1